60 participants
A Randomized Phase II Study of Two Doses of Interferon Alfa-2a (IFN Alfa-2a) in Combination With Zidovudine (AZT) and Dideoxycytidine (ddC) Versus AZT and ddC Only in Patients With HIV Infection and Less Than 400 CD4 Cells/mm3
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2021-11-04
Conditions
- HIV Infections
Interventions
- DRUG
No Results Yet